Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -114,527 | -122,176 | -93,666 | -85,472 | -56,946 |
| Depreciation Amortization | 2,060 | 2,216 | 2,026 | 1,600 | 1,935 |
| Accounts payable and accrued liabilities | 170 | 159 | 837 | -585 | -221 |
| Other Working Capital | -9,666 | 2,068 | 7,765 | 3,474 | 1,164 |
| Other Operating Activity | 20,728 | 21,008 | 9,975 | 9,003 | 6,789 |
| Operating Cash Flow | $-101,235 | $-96,725 | $-73,063 | $-71,980 | $-47,279 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 55,000 | -54,837 |
| PPE Investments | -622 | -1,481 | -1,315 | -3,030 | -5,291 |
| Investing Cash Flow | $-622 | $-1,481 | $-1,315 | $51,970 | $-60,128 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 44,487 | 14,778 | 10,000 | 19,481 | 4,975 |
| Debt Repayment | -47,610 | N/A | N/A | -15,000 | N/A |
| Common Stock Issued | 84,778 | 82,762 | 55,465 | 511 | 75,951 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 81,086 |
| Financing Cash Flow | $81,655 | $97,540 | $65,465 | $4,992 | $162,012 |
| Exchange Rate Effect | -454 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 69,754 | 70,420 | 79,333 | 94,351 | 39,746 |
| End Cash Position | 49,098 | 69,754 | 70,420 | 79,333 | 94,351 |
| Net Cash Flow | $-20,656 | $-666 | $-8,913 | $-15,018 | $54,605 |
| Free Cash Flow | |||||
| Operating Cash Flow | -101,235 | -96,725 | -73,063 | -71,980 | -47,279 |
| Capital Expenditure | -622 | -1,519 | -1,321 | -3,032 | -5,462 |
| Free Cash Flow | -101,857 | -98,244 | -74,384 | -75,012 | -52,741 |